Literature DB >> 20719479

Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.

E Gonzalez-Mira1, M A Egea, M L Garcia, E B Souto.   

Abstract

Packaging small drug molecules, such as non-steroidal anti-inflammatory drugs (NSAIDs) into nanoparticulate systems has been reported as a promising approach to improve the drug's bioavailability, biocompatibility and safety profiles. In the last 20 years, lipid nanoparticles (lipid dispersions) entered the nanoparticulate library as novel carrier systems due to their great potential as an alternative to other systems such as polymeric nanoparticles and liposomes for several administration routes. For ocular instillation nanoparticulate carriers are required to have a low mean particle size, with the lowest polydispersity as possible. The purpose of this work was to study the combined influence of 2-level, 4-factor variables on the formulation of flurbiprofen (FB), a lipophilic NSAID, in lipid carriers currently named as nanostructured lipid carriers (NLC). NLC were produced with stearic acid (SA) and castor oil (CO) stabilized by Tween® 80 (non-ionic surfactant) in aqueous dispersion. A 2(4) full factorial design based on 4 independent variables was used to plan the experiments, namely, the percentage of SA with regard to the total lipid, the FB concentration, the stabilizer concentration, and the storage conditions (i.e., storage temperature). The effects of these parameters on the mean particle size, polydispersity index (PI) and zeta potential (ZP) were investigated as dependent variables. The optimization process was achieved and the best formulation corresponded to the NLC formulation composed of 0.05 (wt%) FB, 1.6 (wt%) Tween® 80 and a 50:50 ratio of SA to CO, with an average diameter of 288 nm, PI 0.245 of and ZP of -29 mV. This factorial design study has proven to be a useful tool in optimizing FB-loaded NLC formulations. Stability of the optimized NLC was predicted using a TurbiScanLab® and the ocular tolerance was assessed in vitro and in vivo by the Eytex® and Draize test, respectively. The developed systems were shown physico-chemically stable with high tolerance for eye instillation.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20719479     DOI: 10.1016/j.colsurfb.2010.07.029

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  21 in total

1.  Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine.

Authors:  Su Li; Zhaoshuai Ji; Meijuan Zou; Xin Nie; Yijie Shi; Gang Cheng
Journal:  AAPS PharmSciTech       Date:  2011-08-03       Impact factor: 3.246

Review 2.  Applications and perspectives of polyphenol-loaded solid lipid nanoparticles and nanostructured lipid carriers for foods.

Authors:  Eunghee Kim; Choongjin Ban; Sang-Oh Kim; Seokwon Lim; Young Jin Choi
Journal:  Food Sci Biotechnol       Date:  2022-05-20       Impact factor: 3.231

3.  Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.

Authors:  Upendra Nagaich; Neha Gulati
Journal:  Drug Deliv Transl Res       Date:  2016-06       Impact factor: 4.617

Review 4.  Lipid-Based Nanocarriers for Ophthalmic Administration: Towards Experimental Design Implementation.

Authors:  Felipe M González-Fernández; Annalisa Bianchera; Paolo Gasco; Sara Nicoli; Silvia Pescina
Journal:  Pharmaceutics       Date:  2021-03-26       Impact factor: 6.321

5.  Formulation and Evaluation of Topical Biodegradable Films Loaded with Levofloxacin Lipid Nanocarriers.

Authors:  Rania S Abdel-Rashid; Eman S El-Leithy; Raghda Abdel-Monem
Journal:  AAPS PharmSciTech       Date:  2021-12-23       Impact factor: 3.246

6.  Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers.

Authors:  Yan Chen; Lei Zhou; Ling Yuan; Zhen-hai Zhang; Xuan Liu; Qingqing Wu
Journal:  Int J Nanomedicine       Date:  2012-06-19

7.  Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide.

Authors:  John Youshia; Amany O Kamel; Abdelhameed El Shamy; Samar Mansour
Journal:  Int J Nanomedicine       Date:  2012-05-17

8.  Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia.

Authors:  Rehab Nabil Shamma; Mona Hassan Aburahma
Journal:  Int J Nanomedicine       Date:  2014-11-26

9.  Nanostructured Lipid Carriers (NLC)-Based Gel for the Topical Delivery of Aceclofenac: Preparation, Characterization, and In Vivo Evaluation.

Authors:  Dilip Patel; Sandipan Dasgupta; Sanjay Dey; Y Roja Ramani; Subhabrata Ray; Bhaskar Mazumder
Journal:  Sci Pharm       Date:  2012-06-18

10.  Crosslinked chitosan-dextran sulfate nanoparticle for improved topical ocular drug delivery.

Authors:  Wanachat Chaiyasan; Sangly P Srinivas; Waree Tiyaboonchai
Journal:  Mol Vis       Date:  2015-10-26       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.